31.19
price down icon0.45%   -0.14
after-market Dopo l'orario di chiusura: 31.60 0.41 +1.31%
loading
Precedente Chiudi:
$31.33
Aprire:
$30.89
Volume 24 ore:
299.94K
Relative Volume:
0.25
Capitalizzazione di mercato:
$2.39B
Reddito:
$13.17M
Utile/perdita netta:
$-199.06M
Rapporto P/E:
-11.38
EPS:
-2.74
Flusso di cassa netto:
$-156.53M
1 W Prestazione:
-1.36%
1M Prestazione:
-0.95%
6M Prestazione:
-21.99%
1 anno Prestazione:
-28.76%
Intervallo 1D:
Value
$30.84
$31.24
Intervallo di 1 settimana:
Value
$30.84
$32.72
Portata 52W:
Value
$26.74
$46.00

Xenon Pharmaceuticals Inc Stock (XENE) Company Profile

Name
Nome
Xenon Pharmaceuticals Inc
Name
Telefono
(604) 484-3300
Name
Indirizzo
200 - 3650 GILMORE WAY, BURNABY
Name
Dipendente
327
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
XENE's Discussions on Twitter

Confronta XENE con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
XENE
Xenon Pharmaceuticals Inc
31.19 2.40B 13.17M -199.06M -156.53M -2.74
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-07 Iniziato Chardan Capital Markets Buy
2025-02-11 Iniziato Deutsche Bank Buy
2024-10-10 Ripresa Raymond James Outperform
2024-10-01 Iniziato H.C. Wainwright Buy
2024-01-04 Iniziato Citigroup Buy
2023-12-08 Iniziato Robert W. Baird Outperform
2023-10-24 Ripresa Cantor Fitzgerald Overweight
2023-04-25 Iniziato Cantor Fitzgerald Overweight
2022-12-14 Iniziato Goldman Buy
2022-12-12 Iniziato Cowen Outperform
2022-11-28 Iniziato Wells Fargo Overweight
2022-10-19 Iniziato Raymond James Outperform
2022-08-29 Iniziato BofA Securities Buy
2022-07-21 Iniziato JP Morgan Overweight
2021-10-28 Iniziato RBC Capital Mkts Outperform
2020-10-02 Iniziato SVB Leerink Outperform
2020-07-21 Iniziato Needham Buy
2020-06-01 Ripresa Jefferies Buy
2020-03-25 Iniziato Wedbush Outperform
2020-01-08 Iniziato William Blair Outperform
2019-09-20 Iniziato Guggenheim Buy
2018-08-08 Reiterato Stifel Buy
2017-03-13 Iniziato Jefferies Buy
2016-10-21 Iniziato Stifel Buy
2016-09-26 Iniziato Guggenheim Buy
2016-04-14 Reiterato Jefferies Buy
2015-10-30 Ripresa Jefferies Buy
2014-12-02 Iniziato Canaccord Genuity Buy
Mostra tutto

Xenon Pharmaceuticals Inc Borsa (XENE) Ultime notizie

pulisher
Jul 23, 2025

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Bought by Bank of New York Mellon Corp - Defense World

Jul 23, 2025
pulisher
Jul 22, 2025

How Xenon Pharmaceuticals Inc. stock performs during market volatilityFree Access to Community - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Xenon Pharmaceuticals Inc. Stock Analysis and ForecastFree Bull & Bear Market Updates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Xenon Pharmaceuticals Inc. a good long term investmentFree Stock Selection - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Xenon Pharmaceuticals Inc. stock priceHigh-octane financial growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Xenon Pharmaceuticals Inc. stockRapid profit acceleration - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Mutual of America Capital Management LLC Buys New Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Jul 21, 2025
pulisher
Jul 20, 2025

Should I buy Xenon Pharmaceuticals Inc. stock before earningsFree Smart Money Stock Analysis - Newser

Jul 20, 2025
pulisher
Jul 19, 2025

(XENE) Investment Analysis and Advice - news.stocktradersdaily.com

Jul 19, 2025
pulisher
Jul 16, 2025

Teacher Retirement System of Texas Reduces Stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

Why Xenon Pharmaceuticals Inc. stock attracts strong analyst attentionReliable High Profit Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Xenon Pharmaceuticals Inc. stock price move sharplyHigh Yield Opportunities - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

We're Hopeful That Xenon Pharmaceuticals (NASDAQ:XENE) Will Use Its Cash Wisely - Yahoo Finance

Jul 14, 2025
pulisher
Jul 10, 2025

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Average Recommendation of “Buy” by Brokerages - Defense World

Jul 10, 2025
pulisher
Jul 10, 2025

Traders Buy Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - Defense World

Jul 10, 2025
pulisher
Jul 08, 2025

How to Take Advantage of moves in (XENE) - news.stocktradersdaily.com

Jul 08, 2025
pulisher
Jul 07, 2025

CFO changes at Biocryst, Xenon, Century, Pyxis - biocentury.com

Jul 07, 2025
pulisher
Jul 06, 2025

RBC Raises Xenon Price Target, Cites Phase III Optimism for Epilepsy Drug - MSN

Jul 06, 2025
pulisher
Jul 04, 2025

Xenon Appoints CEO Ian Mortimer as Interim CFO - The Globe and Mail

Jul 04, 2025
pulisher
Jul 03, 2025

XENE CEO Named Interim CFO After Sherry Aulin Resigns | XENE SEC FilingForm 8-K - Stock Titan

Jul 03, 2025
pulisher
Jun 30, 2025

Xenon Pharmaceuticals Inc.(NasdaqGM:XENE) added to Russell Small Cap Comp Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

Xenon Pharmaceuticals: Riding the Russell Wave to Institutional Inflows and Clinical Milestones? - AInvest

Jun 29, 2025
pulisher
Jun 28, 2025

Xenon Joins the Russell 3000® and Russell 2000® Indexes - The Manila Times

Jun 28, 2025
pulisher
Jun 27, 2025

Xenon Pharmaceuticals added to Russell 3000 and 2000 indexes - Investing.com India

Jun 27, 2025
pulisher
Jun 27, 2025

Xenon Pharmaceuticals Inc. Added to Russell 3000® and Russell 2000® Indexes in Annual Reconstitution - Quiver Quantitative

Jun 27, 2025
pulisher
Jun 26, 2025

Xenon Pharmaceuticals Announces Equity Inducement Grants to New Employees - TipRanks

Jun 26, 2025
pulisher
Jun 25, 2025

Is Xenon Pharmaceuticals, Inc. overvalued or undervalued? - MarketsMojo

Jun 25, 2025
pulisher
Jun 24, 2025

Xenon Announces Appointment of Darren Cline as Chief Commercial Officer - The Globe and Mail

Jun 24, 2025
pulisher
Jun 18, 2025

Long Term Trading Analysis for (XENE) - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 15, 2025

Xenon Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:XENE) - MarketBeat

Jun 15, 2025
pulisher
Jun 15, 2025

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Average Recommendation of “Buy” from Analysts - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

RBC Capital Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Raises Target Price to $57 - 富途牛牛

Jun 14, 2025
pulisher
Jun 13, 2025

Xenon Pharmaceuticals price target raised to $57 from $55 at RBC Capital - Investing.com Canada

Jun 13, 2025
pulisher
Jun 13, 2025

RBC Raises Price Target on Xenon Pharmaceuticals to $57 From $55, Keeps Outperform, Speculative Risk - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

Cantor Fitzgerald Estimates XENE FY2026 Earnings - MarketBeat

Jun 13, 2025
pulisher
Jun 12, 2025

Traders Purchase High Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Xenon Pharmaceuticals (XENE) Up 8.7% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Jun 11, 2025
pulisher
Jun 11, 2025

Brokers Set Expectations for XENE FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Xenon Pharmaceuticals at Goldman Sachs Conference: Strategic Clinical Advances By Investing.com - Investing.com Canada

Jun 10, 2025

Xenon Pharmaceuticals Inc Azioni (XENE) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):